Influence of Carotid Artery Stenting in Patients with Mild Cognitive Impairment

Study in the Influence of Carotid Artery Stenting to Patients with Mild Cognitive Impairment

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-12001879

Enrollment

Unknown

Registered

2012-01-12

Start date

2008-03-03

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild cognitive impairment(MCI)

Interventions

CAS:Carotid Artery Stenting

control:Medication treatment

Eligibility

Sex/Gender

All

Age

55 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) elder than 55 years old;(2) Patients with recently symptomatic ICA stenosis of >50% or asymptomatic ICA stenosis of >70%, measured according to the North American Symptomatic Carotid Endarterectomy Trial( NASCET) criteria or its noninvasive equivalent;(3) Who were diagnosed as MCI.

Exclusion criteria

Exclusion criteria: (1) evidence of other significant stenosis (>50%) in the major arteries of the head or neck; (2) evidence of a acute cerebral infarction need Emergency thrombolysis and (or) emergency stent placement; (3) a history of previous subarachnoid or cerebral hemorrhage; (4) a concomitant neurologic disorder potentially affecting cognitive function (e.g., severe Parkinson disease); (5) being unable to comply with the study assessment; (6) enduring mental illness, or the score of Hamilton Depression Rating Scale (HDRS)>17; (7) moving away or declining to participate.

Design outcomes

Primary

Measure	Time frame
Mini-Mental State Examination( MMSE);Montreal Cognitive Assessment (MoCA);Fuld Object Memory Evaluation (FOM);Rapid Verbal Retrieve (RVR);	—

Countries

China

Contacts

Public ContactHuadong Zhou

zhouhuad@163.com+86 23 6878753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026